HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sensodyne, Nature Made Among Pharmacists’ ‘Most Trusted’ OTC Brands, Survey Says

Executive Summary

The inaugural BrandSpark/Newsweek Most Trusted by Pharmacists Awards honors brands in 86 OTC product categories based on unaided citations by surveyed pharmacists.

You may also be interested in...



OTC Consumer Health Brands Should Not ‘Fear’ Promoting In Physician Channel – Experts

Consumer health brands with ads in doctors’ offices rank high in credibility among consumers and doctors, noted panelists in a recent CHPA-sponsored webinar. Doctors are significantly more likely to recommend brands advertised in their offices, and 73% of consumers are likely to purchase a brand their doctor recommended within one week, according to studies.

Cosmetics Industry In Perplexing Spot: A Trusted Voice, But What Exactly Is The Conversation?

The year 2022 could be a ripe opportunity for industry to inform public opinion amid sweeping policy changes that stand to transform the global cosmetics sector. Consumers may be inclined to listen when business speaks, but that doesn’t mean they’ll like the conversation.

CIR Expert Panel Wants Nano Data For Ingredient Reviews

Are nanoparticle data necessarily relevant to every ingredient assessment undertaken by Cosmetic Ingredient Review’s independent expert panel? Let us be the judge of that, the panel said on 27 September at its 162nd meeting.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel